US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DEFIANCE DAILY TARGET 2X LONG HIMS ETF

25.03

+0.35001.42%

Post-market: 25.200.1747+0.70%19:54 EDT

Volume:187.31K

Turnover:4.66M

Market Cap:60.31M

PE:- -

High:25.84

Open:24.74

Low:24.15

Close:24.68

52wk High:391.58

52wk Low:12.38

Shares:2.41M

Float Shares:2.41M

Volume Ratio:0.68

T/O Rate:7.77%

Dividend:1.98

Dividend Rate:7.91%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Hims & Hers Health is Maintained at Neutral by B of a Securities

HIMS Stock Jumps after Canaccord Raises Price Target to Street-High of $40

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Oruka Therapeutics (ORKA) and Hims & Hers Health (HIMS)

Hims & Hers : Bofa Global Research Raises Price Objective to $36.00 from $25.00

THOMSON REUTERS

Moderately bullish activity in Hims and Hers Health with shares up 5.3%

Analysis-hims' Obesity Drug Business May Get Boost as Employers Drop Coverage

Hims & Hers CFO Oluyemi Okupe sells 18,197 common shares worth $619,043 under 10b5-1 plan

Cboe data suggests bullish flow in Hims and Hers Health with shares up 11.49%

Living Longer Is Big Business. These Stocks Will Benefit. -- Barrons.com

Hims & Hers Health Is Maintained at Overweight by Barclays

U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis

Barclays Keeps Their Buy Rating on Hims & Hers Health (HIMS)

Hims & Hers CTO Mohamed Elshenawy disposes of USD 1.42 million in common shares

Hims & Hers price target raised to $39 from $29 at Barclays

Hims & Hers Stands to Get a Big Chunk of the $2.2B Peptides Market -- Barrons.com

BUZZ-U.S. STOCKS ON THE MOVE-Qualcomm, Robinhood, Mobileye

BUZZ-Leerink sees about $440 million peptide revenue chance for Hims & Hers

Hims & Hers files initial beneficial ownership statement for new director Kofi Owusu Amoo-Gottfried

Hims & Hers Health holds annual shareholder meeting, directors elected

Moderately bullish activity in Hims and Hers Health with shares up 10.7%

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/HIMZ/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"HIMZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIMZ\",,,,,undefined,":{"symbol":"HIMZ","market":"US","secType":"STK","nameCN":"DEFIANCE DAILY TARGET 2X LONG HIMS ETF","latestPrice":25.03,"timestamp":1789588800000,"preClose":24.68,"halted":0,"volume":187310,"hourTrading":{"tag":"盘后","latestPrice":25.2047,"preClose":25.03,"latestTime":"19:54 EDT","volume":22451,"amount":560374.1415,"timestamp":1789602876369,"change":0.1747,"changeRate":0.00698,"amplitude":0.016568},"delay":0,"changeRate":0.014181523500810431,"floatShares":2409608,"shares":2409608,"eps":0,"marketStatus":"Not Yet Opened","change":0.35,"latestTime":"09-16 16:00:00 EDT","open":24.74,"high":25.8426,"low":24.145,"amount":4662578.77341,"amplitude":0.068784,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789632000000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":24.68,"sharesOutstanding":57385000,"nav":24.71,"aum":57317488.97,"dividendRate":0.079105,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":24.88,"preClose":24.68,"latestTime":"09:29 EDT","volume":885,"amount":21994.76694,"timestamp":1789565345679,"change":0.2,"changeRate":0.008104,"amplitude":0.026207},"postHourTrading":{"tag":"盘后","latestPrice":25.2047,"preClose":25.03,"latestTime":"19:54 EDT","volume":22451,"amount":560374.1415,"timestamp":1789602876369,"change":0.1747,"changeRate":0.00698,"amplitude":0.016568},"volumeRatio":0.676819,"impliedVol":1.3081,"impliedVolPercentile":0.1793},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIMZ\",,,,,undefined,":{"symbol":"HIMZ","floatShares":2409608,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.676819,"shares":2409608,"dividePrice":1.98,"high":25.8426,"amplitude":0.068784,"preClose":24.68,"low":24.145,"week52Low":12.3816,"pbRate":"--","week52High":391.58,"institutionHeld":0,"latestPrice":25.03,"eps":0,"divideRate":0.079105,"volume":187310,"delay":0,"ttmEps":0,"open":24.74,"prevYearClose":81.06,"prevWeekClose":24.18,"prevMonthClose":28.37,"prevQuarterClose":48.7861,"fiveDayClose":25.12,"twentyDayClose":25.8,"sixtyDayClose":46.64},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HIMZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-19","symbol":"HIMZ","defaultRemindTime":1773927000000,"type":"split","dateTimestamp":1773892800000,"forFactor":14,"toFactor":1,"ratio":14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HIMZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HIMZ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HIMZ\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2648543734","title":"Hims & Hers Health is Maintained at Neutral by B of a Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2648543734","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648543734?lang=en_us&edition=fundamental","pubTime":"2026-07-01 20:52","pubTimestamp":1782910320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HIMS/analyst-ratings(END) Dow Jones NewswiresJuly 01, 2026 08:52 ET","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIYY","HIMS","HIMZ","BK4196","HIMY","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648154824","title":"HIMS Stock Jumps after Canaccord Raises Price Target to Street-High of $40","url":"https://stock-news.laohu8.com/highlight/detail?id=2648154824","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648154824?lang=en_us&edition=fundamental","pubTime":"2026-07-01 20:16","pubTimestamp":1782908218,"startTime":"0","endTime":"0","summary":"Shares of Hims & Hers ($HIMS) rose in pre-market trading after receiving a new Street-high price target of $40. Canaccord Genuity analyst Maria Rip...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/hims-stock-jumps-after-canaccord-raises-price-target-to-street-high-of-40?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/hims-stock-jumps-after-canaccord-raises-price-target-to-street-high-of-40?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIMZ","HIYY","HMYY","BK4196","HIMY","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648510005","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Oruka Therapeutics (ORKA) and Hims & Hers Health (HIMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2648510005","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648510005?lang=en_us&edition=fundamental","pubTime":"2026-07-01 20:01","pubTimestamp":1782907265,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), Oruka Therapeutics (ORKA) and Hims &...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-oruka-therapeutics-orka-and-hims-hers-health-hims-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-oruka-therapeutics-orka-and-hims-hers-health-hims-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0058720904.USD","BK4196","LU0320765992.SGD","LU0109394709.USD","BK4566","BK4585","LU1057294990.SGD","IE00BJT1NW94.SGD","BK4599","HMYY","LU0868494617.USD","AMGN","LU0889565916.HKD","SG9999001440.SGD","IE0002141913.USD","IE00BJJMRZ35.SGD","HIMZ","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU1061106388.HKD","LU2112291526.USD","HIYY","LU0122379950.USD","LU1571399168.USD","IE0009355771.USD","IE00B2B36J28.USD","LU2242646821.SGD","BK4139","04332","BK4534","IE00B4R5TH58.HKD","BK4533","HIMY","BK4581","ORKA","LU1023059063.AUD","HIMS","LU0289739699.SGD","LU1983299246.USD","LU2089984988.USD","BK4588","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648517550","title":"Hims & Hers : Bofa Global Research Raises Price Objective to $36.00 from $25.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2648517550","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648517550?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:05","pubTimestamp":1782903937,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nAZN4T5E2P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HMYY","HIMY","HIMZ","HIMS","HIYY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646369411","title":"Moderately bullish activity in Hims and Hers Health with shares up 5.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646369411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646369411?lang=en_us&edition=fundamental","pubTime":"2026-06-26 23:55","pubTimestamp":1782489309,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Hims and Hers Health (HIMS), with shares up $1.74, or 5.3%, near $34.45. Options volume running well above average w...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-hims-and-hers-health-with-shares-up-5-3-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-hims-and-hers-health-with-shares-up-5-3-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIYY","HIMS","HIMZ","BK4196","HIMY","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646879143","title":"Analysis-hims' Obesity Drug Business May Get Boost as Employers Drop Coverage","url":"https://stock-news.laohu8.com/highlight/detail?id=2646879143","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646879143?lang=en_us&edition=fundamental","pubTime":"2026-06-25 18:00","pubTimestamp":1782381600,"startTime":"0","endTime":"0","summary":"CORRECTED-ANALYSIS-Hims' obesity drug business may get boost as employers drop coverageCorrects paragraph 15 to reflect that Hims & Hers is one of the most volume-producing of Novo’s partners, and not","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nL1N42O14W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","BK4196","BK4211","BK4585","CI","IE00B19Z3581.USD","HMYY","LU0868494617.USD","BK4190","HIMZ","IE00B19Z3B42.SGD","LU1261432733.SGD","LU2237438978.USD","HIYY","IE00BSNM7G36.USD","ESCA","IE0002270589.USD","HIMY","HIMS","LU0289739699.SGD","BK4588","LU1059921491.USD","TFC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645852702","title":"Hims & Hers CFO Oluyemi Okupe sells 18,197 common shares worth $619,043 under 10b5-1 plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2645852702","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645852702?lang=en_us&edition=fundamental","pubTime":"2026-06-24 06:40","pubTimestamp":1782254411,"startTime":"0","endTime":"0","summary":"Hims & Hers Health CFO Oluyemi Okupe sold 18,197 Class A shares on June 22 at an average $34.03.He exercised options for 6,376 shares at $5.01 the same day.Directly held stake ended at 284,321 shares; an additional 7,853 shares were held indirectly via a trust.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hims & Hers Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 23, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nNDL64Qc8G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers CFO Oluyemi Okupe sells 18,197 common shares worth $619,043 under 10b5-1 plan","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","HIYY","HMYY","BK4196","HIMY","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644103924","title":"Cboe data suggests bullish flow in Hims and Hers Health with shares up 11.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644103924","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644103924?lang=en_us&edition=fundamental","pubTime":"2026-06-19 04:45","pubTimestamp":1781815510,"startTime":"0","endTime":"0","summary":"Cboe data suggests bullish flow in Hims and Hers Health (HIMS), with shares up $3.67, or 11.49%, near $35.55. Options volume more than double the d...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-hims-and-hers-health-with-shares-up-11-49-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-hims-and-hers-health-with-shares-up-11-49-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIYY","HMYY","HIMS","HIMY","BK4196","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644380030","title":"Living Longer Is Big Business. These Stocks Will Benefit. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2644380030","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644380030?lang=en_us&edition=fundamental","pubTime":"2026-06-19 02:15","pubTimestamp":1781806500,"startTime":"0","endTime":"0","summary":"Health is wealth goes the saying. Now it's an investment opportunity, too.The consumerization of healthcare is nothing new, but the pandemic turbocharged its widespread adoption. From telehealth appointments to digital patient portals and wearable trackers, many people began to treat their health like any other retail experience -- whether it's walking into a CVS Health MinuteClinic after doing some shopping, or trying  to estimate the out-of-pocket price for procedures with cost-estimator tools.The upshot is that longevity, i.e. not only living longer but being healthy for longer, could be big business for healthcare companies. TD Cowen analysts estimate that the total addressable market for longevity healthcare exceeds $250 billion, with beneficiaries spanning companies making biological breakthroughs to those using artificial intelligence.\"Tools to measure and screen health status--across blood-based testing, imaging, and wearable--have advanced meaningfully,\" writes lead analyst Da","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1323610961.USD","IE00B19Z3B42.SGD","LU2433249047.HKD","GH","LU0354030438.USD","OWLT","LU1064131342.USD","LU0868494617.USD","LU1059921491.USD","LU1861558580.USD","IE00BFTCPJ56.SGD","LU1923622614.USD","LU1861559042.SGD","BK4550","LU1721429402.USD","IE00BMPRXR70.SGD","IE00BSNM7G36.USD","LU0354030511.USD","LU0170899867.USD","LU0072461881.USD","IE00B7SZLL34.SGD","SG9999004303.SGD","IE00B19Z3581.USD","BK4216","LU1983299246.USD","LU0234572021.USD","LU1061106388.HKD","SGXZ23171101.USD","LU0211331839.USD","LU2125909593.SGD","BK4209","HIYY","LU0345770993.USD","LU2095319765.USD","HIMS","BK4533","LU2125909247.SGD","LU2065171311.SGD","HIMY","NTRA","BK4585","LU1057294990.SGD","LU2065171402.SGD","IE0002270589.USD","BK4535","BK4592","IE00B4R5TH58.HKD","BK4534","LU1914381329.SGD","GB00BDT5M118.USD","SG9999002224.SGD","LU0345770308.USD","LU0106261612.USD","BK4167","IE00BMPRXN33.USD","LU1023059063.AUD","BK4082","LU0289739699.SGD","TDOC","LU0061475181.USD","LU2237957811.SGD","LU2133065610.SGD","LU0162691827.USD","PLNT","BK4007","LU0053671581.USD","LU1989763427.SGD","LU1691799644.USD","LU0122379950.USD","LU1988902786.USD","LU2112291526.USD","BK4548","IE00B2B36J28.USD","LU0058720904.USD","LU2211815571.USD","LU2089984988.USD","IE0009355771.USD","IE00BKVL7J92.USD","LU2210149790.SGD","BK4551","LU0390134368.USD","BK4196","LU0963586101.USD","LU0320765489.SGD","LU0006061336.USD","LU2237957902.USD","LU2324357040.USD","LU0208291251.USD","LU1699723380.USD","SG9999002232.USD","BFLY","LU1571399168.USD","LU2210150020.SGD","BK4567","LU0114720955.EUR","LU0012050646.USD","CVS","LU2065731478.USD","LU1721429741.USD","LU0882574055.USD","MYGN","IE00BZ1G4Q59.USD","BK4568","LU0432979614.USD","HIMZ","BK4121","BTMD","LU2264538146.SGD","HMYY","QTRX","BK4588","BK4504","DXCM","ABT","SGXZ41872573.SGD","IE00BJT1NW94.SGD","LU0266013472.USD","IE00BJJMRZ35.SGD","LU0070302665.USD","CAVA","IE0002141913.USD","BK4139","LU2468319806.SGD","LU2065170008.USD","BK4581","BK4566","LU2065169927.USD","LU1989763690.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644681087","title":"Hims & Hers Health Is Maintained at Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2644681087","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644681087?lang=en_us&edition=fundamental","pubTime":"2026-06-18 23:49","pubTimestamp":1781797740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HIMS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 18, 2026 11:49 ET (15:49 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HMYY","HIMS","HIMZ","HIYY","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644877042","title":"U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis","url":"https://stock-news.laohu8.com/highlight/detail?id=2644877042","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644877042?lang=en_us&edition=fundamental","pubTime":"2026-06-18 15:14","pubTimestamp":1781766857,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Datadog, Jabil, PrologisJune 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Datadog, Jabil an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nL4N42Q0IZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DUK","HIYY","INDV","NRIX","EFSC","ESS","FR","EFX","LU1861215975.USD","LU2211815571.USD","EGP","CME","LU2236285917.USD","BIIB","HMYY","MU","CPT","DDOG","FROG","BTSG","GRDN","EXR","KMX","LXP","AJG","PAYO","BDSX","MULL","MUU","PEP","BXP","TXG","HIMZ","MUD","LU0342679015.USD","HIMS","HIMY","NUE","DOGD","JBL","ANDE","CAG","ILMN","EPRT","PK","INTU","MAA","AHR","TECH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644977749","title":"Barclays Keeps Their Buy Rating on Hims & Hers Health (HIMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2644977749","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644977749?lang=en_us&edition=fundamental","pubTime":"2026-06-18 14:27","pubTimestamp":1781764020,"startTime":"0","endTime":"0","summary":"Barclays analyst Glen Santangelo maintained a Buy rating on Hims & Hers Health today and set a price target of $39.00. Santangelo covers the Health...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-keeps-their-buy-rating-on-hims-hers-health-hims-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-keeps-their-buy-rating-on-hims-hers-health-hims-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIYY","HIMY","HMYY","HIMS","BK4196","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644727968","title":"Hims & Hers CTO Mohamed Elshenawy disposes of USD 1.42 million in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2644727968","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644727968?lang=en_us&edition=fundamental","pubTime":"2026-06-18 06:51","pubTimestamp":1781736670,"startTime":"0","endTime":"0","summary":"Hims & Hers Health CTO Mohamed Elshenawy acquired 282,597 Class A shares on June 15 via RSU vesting and settlement.Issuer withheld 151,534 shares at USD 30.17 to cover tax obligations tied to the vesting.Elshenawy sold 30,040 shares on June 17 at USD 31.5, leaving 101,023 shares beneficially owned.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hims & Hers Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 17, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL4nYYlx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers CTO Mohamed Elshenawy disposes of USD 1.42 million in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIYY","HIMZ","HIMY","HIMS","HMYY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644268147","title":"Hims & Hers price target raised to $39 from $29 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2644268147","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644268147?lang=en_us&edition=fundamental","pubTime":"2026-06-18 02:55","pubTimestamp":1781722542,"startTime":"0","endTime":"0","summary":"Barclays raised the firm’s price target on Hims & Hers (HIMS) to $39 from $29 and keeps an Overweight rating on the shares. A combination of weight...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/hims-hers-price-target-raised-to-39-from-29-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/hims-hers-price-target-raised-to-39-from-29-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HMYY","HIMY","HIMZ","BK4196","HIYY","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644760359","title":"Hims & Hers Stands to Get a Big Chunk of the $2.2B Peptides Market -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2644760359","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644760359?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:19","pubTimestamp":1781641140,"startTime":"0","endTime":"0","summary":"That buzzy peptide market that Hims & Hers wants in on could be worth close to $2.2 billion next year for the telehealth industry, according to a new estimate. And the amount for Hims & Hers: $440 million, or about a fifth of the total.The numbers, from investment bank Leerink Partners, are based on sales estimates for seven peptides that a Food and Drug Administration panel will review in late July.Some peptides -- the building blocks of protein -- are already approved by the FDA for use in prescription weight-loss drugs like Ozempic and Wegovy.But the Leerink estimates are focused on peptides geared toward \"wellness-minded consumers,\" which have grown in popularity on social media for uses like healing injuries and promoting longevity. They often are taken by injection.This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HIMS","HIMY","HMYY","HIMZ","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643751790","title":"BUZZ-U.S. STOCKS ON THE MOVE-Qualcomm, Robinhood, Mobileye","url":"https://stock-news.laohu8.com/highlight/detail?id=2643751790","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643751790?lang=en_us&edition=fundamental","pubTime":"2026-06-16 19:34","pubTimestamp":1781609654,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Qualcomm, Robinhood, Mobileye Workspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nL6N42O0S7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HOOY","HOOD","LU1261432733.SGD","LU0868494617.USD","BK4157","HOOX","LU1861558580.USD","LU1974910355.USD","LU1861559042.SGD","LU1244550577.SGD","BK4515","IE00BSNM7G36.USD","IE00BGHQDM52.EUR","LU1823568750.SGD","BK4598","SG9999015952.SGD","HOOI","BK4512","HODU","LU1496350502.SGD","QCMU","HIYY","SG9999015986.USD","LU1069344957.HKD","LU0868494708.USD","ALVO","HIMS","LU2065171311.SGD","HIMY","BK4605","BK4585","BK4612","BK4124","LU2065171402.SGD","HUN","BK4534","GB00BDT5M118.USD","SG9999002224.SGD","LU1066053197.SGD","NBP","BK4532","LU1066051498.USD","BK4554","LU0061475181.USD","MBLY","LU0079474960.USD","HOII","LU1046421795.USD","SG9999015945.SGD","BK4141","LU2247934214.USD","LU1119994496.HKD","LU1084165304.USD","LU1244550221.USD","LU0054578231.USD","BK4539","BK4551","LU2106854487.HKD","BK4196","HOOZ","LU1035775433.USD","BK4604","BK4098","SG9999002232.USD","ROBN","BK4561","HOOG","IE00BVYPNQ40.USD","QCMD","MAC","LU1917777945.USD","QCOM","HIMZ","BK4127","LU0942090050.USD","HOYY","LU1244550494.USD","SG9999015978.USD","LU2023250504.SGD","HMYY","BK4588","BK4527","BK4573","LU1066051225.USD","BK4547","LU1066051811.HKD","BK4080","LU0081259029.USD","QCML","IE00BVYPNP33.GBP","BK4579","HOOW","BK4575","BK4139","BK4231","SG9999001424.SGD","LU2065170008.USD","BK4581","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643755609","title":"BUZZ-Leerink sees about $440 million peptide revenue chance for Hims & Hers","url":"https://stock-news.laohu8.com/highlight/detail?id=2643755609","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643755609?lang=en_us&edition=fundamental","pubTime":"2026-06-16 18:12","pubTimestamp":1781604749,"startTime":"0","endTime":"0","summary":"BUZZ-Leerink sees about $440 million peptide revenue chance for Hims & Hers** Leerink Partners stimates a ~$2.2 bln telehealth peptide market, translating to ~$440 mln revenue and about $70 mln in core profit opportunity for Hims & Hers HIMS.N ** Brokerage says narrower prescribing could halve the opportunity to ~$1.1 bln market, ~$220 mln revenue and about $25 mln in core profit** Says opportunity hinges on July FDA advisory panel weighing use of 7 peptides in compounding** Notes commercialization unlikely before end-2026, with meaningful upside seen from 2027 and beyond** Flags safety, efficacy and prescribing limits as key risks to uptake** Leerink rates stock “market perform”, sees near-term focus on GLP-1 profitability** Including session's move, stock down ~7% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nL4N42O0SL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HIMS","BK4196","HMYY","HIMZ","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643786009","title":"Hims & Hers files initial beneficial ownership statement for new director Kofi Owusu Amoo-Gottfried","url":"https://stock-news.laohu8.com/highlight/detail?id=2643786009","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643786009?lang=en_us&edition=fundamental","pubTime":"2026-06-16 05:13","pubTimestamp":1781558033,"startTime":"0","endTime":"0","summary":"Hims & Hers Health filed a Form 3 naming Kofi Owusu Amoo-Gottfried as a director, dated June 11, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hims & Hers Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 15, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL3rt01s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HMYY","HIMZ","HIMS","HIMY","HIYY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643278678","title":"Hims & Hers Health holds annual shareholder meeting, directors elected","url":"https://stock-news.laohu8.com/highlight/detail?id=2643278678","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643278678?lang=en_us&edition=fundamental","pubTime":"2026-06-16 05:03","pubTimestamp":1781557412,"startTime":"0","endTime":"0","summary":"Hims & Hers Health held its annual shareholder meeting on June 11, 2026.Shareholders selected nine directors to serve through the 2027 annual meeting.KPMG was ratified as independent registered public accounting firm for fiscal 2026.Shareholders passed a non-binding advisory vote on executive pay.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hims & Hers Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 15, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL7xRzWz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HMYY","BK4196","HIMZ","HIMS","HIMY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643788944","title":"Moderately bullish activity in Hims and Hers Health with shares up 10.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643788944","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643788944?lang=en_us&edition=fundamental","pubTime":"2026-06-16 02:35","pubTimestamp":1781548537,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Hims and Hers Health (HIMS), with shares up $2.87, or 10.7%, near $29.69. Options volume running well above average ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-hims-and-hers-health-with-shares-up-10-7-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-hims-and-hers-health-with-shares-up-10-7-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","HIMS","HIMY","HMYY","HIMZ","HIYY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}